Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Overcoming technical variation and biological variation in quantitative proteomics.

Mark P Molloy1, Erin E Brzezinski, Junqi Hang

  • 1Pfizer Global Research & Development, Ann Arbor Laboratories, Ann Arbor, MI 48105, USA. mark.molloy@pfizer.com

Proteomics
|November 20, 2003
PubMed
Summary

Quantitative proteomics faces challenges from technical and biological variation. Understanding and managing these variations is crucial for reliable protein expression analysis in drug discovery and research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic biomarkers of distant metastasis following curative-intent resection of early-stage rectal cancer.

Clinical proteomics·2026
Same author

Unveiling novel biomarkers for diabetes-related complications through large-scale proteomics analysis: A FIELD sub-study.

Journal of diabetes and its complications·2026
Same author

ASO Visual Abstract: Circulating Extracellular Vesicle Biomarkers as Diagnostic and Prognostic Biomarkers of Liver Metastasis in Colorectal Cancer: A Systematic Review.

Annals of surgical oncology·2026
Same author

Integrating thermal liquid biopsy, clinical data, and mass spectrometry for early diagnosis and biomarker discovery in colorectal cancer.

iScience·2026
Same author

Circulating Extracellular Vesicle Biomarkers as Diagnostic and Prognostic Biomarkers of Liver Metastasis in Colorectal Cancer: A Systematic Review.

Annals of surgical oncology·2026
Same author

Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size.

Cancer research communications·2025

Area of Science:

  • Proteomics
  • Molecular Biology
  • Biotechnology

Background:

  • Quantitative proteomics measures protein expression differences across experimental conditions.
  • Technical and biological variation are major obstacles to accurate quantitative proteomic analysis.
  • Biological variation becomes more significant in drug discovery and development, from in vitro to clinical stages.

Purpose of the Study:

  • To raise awareness of technical and biological variation in quantitative proteomics.
  • To demonstrate the impact of these variations on experimental outcomes.
  • To provide insights for designing experiments that overcome variation challenges.

Main Methods:

  • Case studies were used to monitor variation across diverse sample types including bacteria, cell lines, primary cultures, and human subjects.

Related Experiment Videos

  • Two-dimensional electrophoresis was employed to define the degree of technical variation.
  • Experiment-to-experiment variation was assessed to understand biological variability.

    • Main Results:

    • Technical variation from two-dimensional electrophoresis was quantified as a 20-30% coefficient of variation.
    • Biological variation exhibited a broader range, dependent on sample type.
    • Case studies highlighted the variability encountered across different biological systems.

    Conclusions:

    • Technical and biological variation are critical factors in quantitative proteomic experimental design.
    • Strategies to mitigate variation are essential for achieving statistically significant results.
    • Effective experimental design is key to overcoming challenges in quantitative proteomic research.